Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 17 citing articles:

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Comparison of humoral and cellular immune responses between ChAd-BNT heterologous vaccination and BNT-BNT homologous vaccination following the third BNT dose: A prospective cohort study
Wooho Sim, Hyunhye Kang, Jin Jung, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Determinants of species-specific utilization of ACE2 by human and animal coronaviruses
Qingxing Wang, Sabrina Noettger, Qinya Xie, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 920-920
Open Access | Times Cited: 7
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose
Giuseppina Sanna, Alessandra Marongiu, Davide Firinu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination
Ching‐Fen Shen, Yi-Chen Fu, Tzong‐Shiann Ho, et al.
Clinical Immunology (2023) Vol. 251, pp. 109342-109342
Open Access | Times Cited: 4
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
Natalie Heinen, Corinna Marheinecke, Clara Bessen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice
Dominik Pflumm, Alina Seidel, Fabrice Klein, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses
Clarice Monteiro Vianna, Glória Regina da Silva e Sá, Maria Vitória Hadland Seid, et al.
Memórias do Instituto Oswaldo Cruz (2024) Vol. 119
Open Access
A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines
Arnone Nithichanon, Ludthawun Kamuthachad, Kanin Salao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays
Hiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1694-1694
Open Access | Times Cited: 1
Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 disease
Gustavo Acosta‐Altamirano, Elizabeth Garduño-Javier, Victoria Hernández-Gómez, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 23, pp. 7905-7916
Open Access | Times Cited: 2
Determinants of species-specific utilization of ACE2 by human and animal coronaviruses
Qingxing Wang, Sabrina Noettger, Qinya Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
What Proportion of Population has achieved Cellular Immunity against SARS-CoV-2 after Booster Vaccination: A Cross-sectional Study
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Research Square (Research Square) (2022)
Open Access
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top